Psychiatry and Mental Health

1-16 of 71

• 

  RestartResume

  Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms

  RestartResume

  Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms

  NeuroFrontiers

  Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Desiree Matthews, PMHNP-BC

• 

  RestartResume

  Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions

  RestartResume

  Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions

  NeuroFrontiers

  Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions

  • 

    

    Shelina Ramnarine, PhD

  • 

    

    Michelle Scargle, MD

  • 

    

    Margaret Emerson, DNP, APRN, PMHNP-BC

• 

  RestartResume

  Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden

  RestartResume

  Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden

  Global Neurology Academy

  Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden

  • 

    

    Brian P. McDonough, MD, FAAFP

  • 

    

    Ahmed Makhlouf, MD

• 

  RestartResume

  Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients

  RestartResume

  Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients

  NeuroFrontiers

  Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Ragy R. Girgis, MD, MS

  • 

    

    Desiree Matthews, PMHNP-BC

• 

  RestartResume

  Understanding Schizophrenia: The Role of Neurotransmission and Inflammation

  RestartResume

  Understanding Schizophrenia: The Role of Neurotransmission and Inflammation

  NeuroFrontiers

  Understanding Schizophrenia: The Role of Neurotransmission and Inflammation

  • 

    

    Jeffrey A. Lieberman, MD

• 

  RestartResume

  Harnessing AI to Predict and Prevent Schizophrenia Relapse

  RestartResume

  Harnessing AI to Predict and Prevent Schizophrenia Relapse

  NeuroFrontiers

  Harnessing AI to Predict and Prevent Schizophrenia Relapse

  • 

    

    Matcheri S. Keshavan, MD

• 

  RestartResume

  Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach

  RestartResume

  Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach

  NeuroFrontiers

  Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach

  • 

    

    Shelina Ramnarine, PhD

  • 

    

    Apurva Bhatt, MD

  • 

    

    Shannon Pagdon, BA

• 

  RestartResume

  Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access

  RestartResume

  Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access

  NeuroFrontiers

  Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    David Kimhy, PhD

• 

  RestartResume

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  RestartResume

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  CME/CE

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  0.25 credits

  • 

    

    Christoph U. Correll, MD

  • 

    

    Jonathan M. Meyer

  0.25 credits

• 

  RestartResume

  From Resistance to Response: Evolving Strategies in MDD Management

  RestartResume

  From Resistance to Response: Evolving Strategies in MDD Management

  CME/CE Broadcast Replay

  From Resistance to Response: Evolving Strategies in MDD Management

  1.00 credit

  • 

    

    Joseph F. Goldberg, MD

  1.00 credit

• 

  RestartResume

  Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression

  RestartResume

  Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression

  NeuroFrontiers

  Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression

• 

  RestartResume

  Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones

  RestartResume

  Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones

  NeuroFrontiers

  Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones

  • 

    

    John Golden

  • 

    

    Michael Greenberg, MD

• 

  RestartResume

  Transforming Clinician Wellness: EEG Headphones Helping with Burnout

  RestartResume

  Transforming Clinician Wellness: EEG Headphones Helping with Burnout

  NeuroFrontiers

  Transforming Clinician Wellness: EEG Headphones Helping with Burnout

  • 

    

    John Golden

  • 

    

    Michael Greenberg, MD

• 

  RestartResume

  Mapping Brain Atrophy in Schizophrenia

  RestartResume

  Mapping Brain Atrophy in Schizophrenia

  Neurology and Neurosurgery

  Mapping Brain Atrophy in Schizophrenia

  • 

    

    Ahmed Makhlouf, MD

• 

  RestartResume

  Understanding Schizophrenia: Early Intervention and Prevention Strategies

  RestartResume

  Understanding Schizophrenia: Early Intervention and Prevention Strategies

  Global Neurology Academy

  Understanding Schizophrenia: Early Intervention and Prevention Strategies

  • 

    

    Joseph F. Goldberg, MD

• 

  RestartResume

  Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance

  RestartResume

  Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance

  Global Neurology Academy

  Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance

  • 

    

    Joseph F. Goldberg, MD

• Prev
• 1
• 2
• 3
• 4
• 5
• Next